US 11291709
Pharmaceutical compositions and methods for fabrication of solid masses comprising TNF-inhibiting antibodies
granted A61KA61K38/26A61K38/28
Quick answer
US patent 11291709 (Pharmaceutical compositions and methods for fabrication of solid masses comprising TNF-inhibiting antibodies) held by Rani Therapeutics, LLC expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rani Therapeutics, LLC
- Grant date
- Tue Apr 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K38/26, A61K38/28, A61K9/2018, A61K9/2027